Traumatic spinal cord injurys secondary injury cascade the secondary injury cascade is a series of changes that begin within just a few hours after the sci and may continue months past the initial injury. You are cordially invited to attend the 2018 annual meeting of stockholders of axsome therapeutics, inc. Branford is cts quiet bioscience startup hub hartford. Fyn kinase inhibition as a novel therapy for alzheimers. After more than doubling, esperion therapeutics, inc. Cara, a biopharmaceutical company focused on developing. Axerion of new haven, connecticut, through its eli whitney fund. Hyperion therapeutics is a biopharmaceutical company focused on creating treatments for urea cycle disorders and other rare diseases. See who you know at axerion therapeutics, leverage your professional network, and get hired. George maynard president and chief scientific officer. A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the.
Axerion therapeutics october 2010 january 2014 3 years 4. This drug is currently developed by cara therapeutics. The work we do is guided by people living with rare and devastating diseases. Intarcia therapeutics rethinking the future of medicine. We are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives. If you do not receive an email within 10 minutes, your email address may not be registered, and you may need to create a new wiley online library. He has focused his academic and business career on the application of developmental biology to. New haven, ct, usa i may 1, 2012 i axerion therapeutics, inc. Renetxs erika smith fights the good fight against spinal. Ct invests in yale alzheimers therapy hartford business. Pit utilizes antibody conjugates that accumulate at the tumor after systemic infusion and can be activated with light to induce rapid, specific, and robust tumor destruction. Facebook view on facebook linkedin view on linkedin contact email kim. Ovesco has developed a clipping system that imitates the mechanics the geometry and force pattern of a surgical suture, but with advantages.
Jane pritchett henderson has been appointed vp of business development for ista. Siteone therapeutics is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids. Aileron therapeutics announces the promotion of richard j. Translational neuropharmacology consulting, llc, potomac, md, usa. Antivirulence cmannosides as antibioticsparing, oral therapeutics for urinary tract infections. Alrn, the clinicalstage leader in the field of stabilized, cellpermeating peptides, announced today the promotion of richard j. Alexion is a global biopharmaceutical company focused on developing lifechanging therapies for people living with rare disorders. The regulation and function of lactate dehydrogenase a. Contact siteone therapeutics, headquartered in bozeman, montana with a research team in south san francisco, california, is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids. Using proprietary assays, cognition therapeutics inc. Learn how to convert outlook e mails to pdf with adobe acrobat in windows 1087.
Axerion therapeutics is focused on the research and development of therapeutics for neurological diseases and injuries. Alzheimers disease ad is a devastating neurodegenerative disorder, afflicting more than onethird of people over the age of 85. Fimbrion and gsk to develop novel antibacterial therapy for urinary tract infections. About us celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline includes immunotherapies and other targeted biologics derived from a broad set of complementary technologies which have the ability to engage the human immune system andor directly inhibit tumors to treat specific types of cancer or other diseases. Fimbrion therapeautics pioneers antivirulence solutions to treat utis. Living with a rare disease isnt just about the treatment, its also about channeling uncertainty and fear into something. Ptct today announced that on october 25, 2019 it approved nonstatutory stock options to purchase an aggregate of 339,875 shares of its common stock to 27 new employees. Axerion of new haven, connecticut, through its eli. The expression vector encodes aa residues 10 of human ngr1 with the cys266ala and cys309ala substitutions fused to the fc domain of human igg1, as described for rat protein previously.
The lots will have a staggered closing time with 2 closing every minute in numerical order. Clinical practice guidelines for the management of degenerative cervical myelopathy and acute traumatic spinal cord injury. While many therapies for ad are in latestage clinical testing, rational drug design based on distinct signaling pathways in this disorder is only now emerging. Intarcia therapeutics is dedicated to redesigning the treatment of chronic disease. With technology licensed from the university of tuebingen, ovesco endoscopy has set out to address one of the biggest challenges of notes procedures. New havenbased biotech company advances innovative treatments for neurological injuries and diseases.
Human ngr10fc was expressed in a stable chos cell line at axerion therapeutics. Axerion was established in new haven to develop and commercialize intellectual property licensed from dr. Wanstall to chief financial officer and treasurer, effective immediately. In 2010, strittmatter formed a company called axerion therapeutics with the yale office of cooperative research. The awards were made pursuant to the nasdaq inducement grant exception as a component of the new hires employment. A branford diagnostics biotech that developed a handheld device to detect organisms that cause infectious diseases is expanding its footprint in the shoreline town with a planned move to a new 16,200squarefoot facility. The company is also using chitin as the basis for programs in novel allergy and asthma therapies, vaccine adjuvants, and nutritional products. Cara tannenbaum, who was appointed by nemer to help lead the cancovid. The production of human ngr10fc by expression in a stable chos cell line at axerion therapeutics has been described. He and his team spent a halfdozen years investigating the bodys inability to repair itself following injury to the central nervous system, and developing a drug to block growth inhibitors.
The cover image representing article number 1900161 by jonathan f lovell and co. View george maynards profile on linkedin, the worlds largest professional community. This months profile group, alzheimers startups face a discovery and clinical crossroads, features profiles of alzprotect, axerion therapeutics, cognition therapeutics and galantos pharma. Degenerative cervical myelopathy, spinal cord injury. On the day the auction is set to close, each lot will clearly countdown the time left until closing.
Intravitreal delivery of human ngrfc decoy protein. Chitin may be the second most common molecule on earth. It forms a new principle to treat chronic or postoperative pain by a peripheral acting. Gaba and schizophrenia targets and emerging therapies. Therapeutics definition of therapeutics by the free. Aspyrian therapeutics is a clinical stage oncology company developing novel precisiontargeted therapies based on the photoimmunotherapy technology pit platform. The project involves developing a compound nogo receptor decoy to rewire nerve cells that promote the recovery of neurological function. Based at yale university in new haven, the team found that mice with ab plaques but no prpc showed no cognitive impairment. Axerion therapeutics is a biotech company focused on developing innovative. Henderson was most recently chief financial officer and executive vp. Development of nogo receptor decoy for the treatment of spinal cord injury, george maynard, phd, axerion therapeutics, inc. Stock protein solutions at 10 mgml were stable for greater than 1 year at.
Addex therapeutics is a clinicalstage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Abstract axonal growth and neurological recovery after traumatic spinal cord injury sci is limited by the presence of inhibitory proteins in myelin, several of which act via the ngr1 protein in n. Regulation of axonal regeneration by the level of function. Branford biotech expanding to bigger space after raising. We are rethinking the future of medicine with people at the center of the experience. How to save outlook email as pdf 3 methods available. Pdf cr845 difelikefalin, a kappa receptors agonist in phase iii. Human ngrfc decoy protein via lumbar intrathecal bolus. The current knowledge of the role of ldha in the brain and its potential as a therapeutic target for brain tumors will also be highlighted. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext.
1259 1182 329 1534 665 723 933 596 335 1382 5 176 942 776 79 585 557 3 1341 336 711 532 749 1476 1101 826 411 197 569 279 851 493 1196 1134 1245 638 133 1280 407 366 735 1369 1406 1253 474 815 464